Black Friday Bargain Stock: Akamai

Tech is dirt cheap right now. But few tech stocks are as cheap as Rule Breakers pick Akamai Technologies (Nasdaq: AKAM  ) , thanks to its minuscule 0.85 PEG ratio.

Now, to be fair, the PEG is anything but a perfect metric, since it compares projected growth -- that is, Wall Street's best guess -- with a forward-looking P/E ratio. Were you to instead perform a discounted cash flow analysis of Akamai, you might find the stock to be expensive, as S&P did.

Such is the nature of growth investing.

But is that really so bad? Not at all. Rocket stocks like Akamai are often the best values you can buy. They'll take decades to reach orbit, setting dozens of record highs along the way. For these stocks, the PEG is a highly useful measurement, for it ascribes value in context.

Put differently: Where is a Black Friday sale worth more? Wal-Mart? Or Nordstrom? Exactly.

Cheap stocks, in context
Back to the PEG. Here, it shows you just how good my Fool compadres are at picking superior stocks. (Bummer.) Have a look at how Akamai compares to the five fastest growers in today's throw-down:


Projected P/E








ViroPharma (NASDAQ:VPHM)

12.21 0.81

Akamai Technologies



Tata Motors (NYSE:TTM)



Dr. Reddy's Laboratories (NYSE:RDY)



Source: Capital IQ, a division of Standard & Poor's.

Yeah, I see it, too. Clothing company Volcom looks like a screaming buy. So does ViroPharma. So does ... Oh, heck, they all look like great stocks.

So that's it, right? We're done? Not so fast. Just as the PEG aims to measure the value of a stock in context, we analysts, in using it, must take steps to understand the quality of the growth that undergirds our assumptions.

The price of a premium
Can we assume that Akamai will improve its bottom line by at least 26% annually over the next five years, as the Street predicts? I think so, for Akamai boasts an extraordinary competitive advantage.

Here's how a bearish researcher from Deutsche Bank, who attended Akamai's analyst day earlier this month, described it to the good folks at RTT News:

The analyst came away from the detailed review of the business ... with the belief that Akamai has a differentiated technology solution relative to traditional [content delivery networks] and a long-term sustainable competitive edge. (Emphasis added.)

Once again, folks, this analyst is bearish on Akamai over the short term.

But over the long haul, he sees a stock that's worth owning. Why don't we break down the elements of the edge in which Deutsche Bank places so much faith? There are three:

  1. Software. Contrary to popular belief, Akamai's primary advantage isn't with its network of 28,000 servers but with a patented software algorithm, which, in the past, it has successfully protected via the courts.
  2. Scale. Even though the network isn't as important as the algorithm, we ought not forget it, either. Akamai spent billions in capital to develop global relationships with Internet service providers that host its servers. Duplicating that wouldn't just be expensive; it could be impossible.
  3. Balance sheet. Akamai, with more than $500 million in cash and investments and $200 million in debt that's practically guaranteed to be converted into stock (which, by the way, has already been accounted for in Akamai's diluted share count), has more than twice as much net cash as any of its peers.

Do you know any other digital firm that boasts similar advantages? What's that? Google (Nasdaq: GOOG  ) , you say? Indeed, sir. Like DoubleGoo, Akamai is a well-funded gorilla that dominates its industry today and, if the skeptics are to be believed, should continue to for years to come. What other stock in this contest can claim that?

None, I'd say. If you agree, go to this page in our 100% free Motley Fool CAPS research database and rate Akamai to outperform the S&P 500. Our editors will tally your votes and reveal your choice for the best Black Friday bargain stock next week.

Ready for more Fool-light specials? Dash to the rest of the series here.

Read/Post Comments (0) | Recommend This Article (8)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 540583, ~/Articles/ArticleHandler.aspx, 10/27/2016 10:57:08 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,180.95 -18.38 -0.10%
S&P 500 2,136.09 -3.34 -0.16%
NASD 5,235.22 -15.05 -0.29%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/27/2016 10:41 AM
AKAM $68.55 Up +0.85 +1.26%
Akamai Technologie… CAPS Rating: ****
GOOGL $815.09 Down -7.01 -0.85%
Alphabet (A shares… CAPS Rating: *****
RDY $49.53 Up +0.97 +1.99%
Dr. Reddy's Labora… CAPS Rating: ****
TTM $39.18 Up +0.28 +0.72%
Tata Motors CAPS Rating: ****
VLCM.DL $0.00 Down +0.00 +0.00%
Volcom, Inc. CAPS Rating: ***
VPHM.DL $0.00 Down +0.00 +0.00%
ViroPharma CAPS Rating: ***
ZUMZ $22.13 Up +0.03 +0.11%
Zumiez CAPS Rating: **